The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity
Open Access
- 13 February 2024
- journal article
- research article
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 13 (1) , 2297553
Abstract
SARS-CoV-2 Omicron subvariants are still emerging and spreading worldwide. These variants contain a high number of polymorphisms in the spike (S) glycoprotein that could potentially impact their pathogenicity and transmission. We have previously shown that the S:655Y and P681H mutations enhance S protein cleavage and syncytia formation. Interestingly, these polymorphisms are present in Omicron S protein. Here, we characterized the cleavage efficiency and fusogenicity of the S protein of different Omicron sublineages. Our results showed that Omicron BA.1 subvariant is efficiently cleaved but it is poorly fusogenic compared to previous SARS-CoV-2 strains. To understand the basis of this phenotype, we generated chimeric S protein using combinations of the S1 and S2 domains from WA1, Delta and Omicron BA.1 variants. We found that the S2 domain of Omicron BA.1 hindered efficient cell-cell fusion. Interestingly, this domain only contains six unique polymorphisms never detected before in ancestral SARS-CoV-2 variants. WA1614G S proteins containing the six individuals S2 Omicron mutations were assessed for their fusogenicity and S surface expression after transfection in cells. Results showed that the S:N856K and N969K substitutions decreased syncytia formation and impacted S protein cell surface levels. However, we observed that "first-generation" Omicron sublineages that emerged subsequently, had convergently evolved to an enhanced fusogenic activity and S expression on the surface of infected cells while "second-generation" Omicron variants have highly diverged and showed lineage-specific fusogenic properties. Importantly, our findings could have potential implications in the improvement and redesign of COVID-19 vaccines.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (75N93021C00014)
- Belgian American Education Foundation
- Swiss National Science Foundation (P500PB_206818)
This publication has 60 references indexed in Scilit:
- Syncytia formation by SARS‐CoV‐2‐infected cellsThe EMBO Journal, 2020
- Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike ProteinACS Central Science, 2020
- TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cellsLife Science Alliance, 2020
- Introductions and early spread of SARS-CoV-2 in the New York City areaScience, 2020
- Site-specific glycan analysis of the SARS-CoV-2 spikeScience, 2020
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung CellsMolecular Cell, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samplesNature Protocols, 2017
- Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptideVirology, 1975
- Activation of influenza A viruses by trypsin treatmentVirology, 1975